<VariationArchive RecordType="classified" VariationID="16711" VariationName="NM_203342.2(EPB41):c.-159_159del" VariationType="Deletion" Accession="VCV000016711" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-17" DateCreated="2018-04-02" MostRecentSubmission="2018-04-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31750" VariationID="16711">
      <GeneList>
        <Gene Symbol="EPB41" FullName="erythrocyte membrane protein band 4.1" GeneID="2035" HGNC_ID="HGNC:3377" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1p35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="28887100" stop="29120041" display_start="28887100" display_stop="29120041" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="29213602" stop="29446557" display_start="29213602" display_stop="29446557" Strand="+" />
          </Location>
          <OMIM>130500</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_203342.2(EPB41):c.-159_159del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.2-p34</CytogeneticLocation>
      </Location>
      <XRefList>
        <XRef ID="CA211229" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="130500.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">PMID 8423235 says that the deletion comprises the first two coding exons from cDNA sequencing, but no genomic sequencing is given or described.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_203342.2(EPB41):c.-159_159del AND Elliptocytosis 1" Accession="RCV000018191" Version="30">
        <ClassifiedConditionList TraitSetID="5478">
          <ClassifiedCondition DB="MedGen" ID="C2678497">Elliptocytosis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1990-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1990-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-04-02" MostRecentSubmission="2018-04-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">3965051</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6894932</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7255153</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2384598</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3722387</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3194408</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5478" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1146" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Elliptocytosis 1</ElementValue>
                <XRef ID="Elliptocytosis+1/8303" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012731" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">4.1- TRAIT</ElementValue>
                <XRef Type="MIM" ID="611804" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">4.1-MINUS TRAIT</ElementValue>
                <XRef Type="MIM" ID="611804" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ELLIPTOCYTOSIS, RHESUS-LINKED TYPE</ElementValue>
                <XRef Type="MIM" ID="611804" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PROTEIN 4.1 OF ERYTHROCYTE MEMBRANE, DEFECT OF</ElementValue>
                <XRef Type="MIM" ID="611804" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EL1</ElementValue>
                <XRef Type="MIM" ID="611804" DB="OMIM" />
              </Symbol>
              <XRef ID="288" DB="Orphanet" />
              <XRef ID="C2678497" DB="MedGen" />
              <XRef ID="MONDO:0012731" DB="MONDO" />
              <XRef Type="MIM" ID="611804" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38470" SubmissionDate="2018-03-29" DateLastUpdated="2018-04-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="130500.0001_ELLIPTOCYTOSIS 1" title="EPB41, 318-BP DEL_ELLIPTOCYTOSIS 1" />
        <ClinVarAccession Accession="SCV000038470" DateUpdated="2018-04-02" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1990-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">This mutation was first reported by Feo et al. (1980) and Tchernia et al. (1981) in homozygotes and heterozygotes and by Alloisio et al. (1985) in heterozygotes. In this form of elliptocytosis (EL1; 611804), Takakuwa et al. (1986) demonstrated restitution of normal membrane stability by incorporation of purified protein 4.1 into deficient red cells by exchange hemolysis.</Attribute>
              <Citation>
                <ID Source="PubMed">7255153</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">6894932</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3965051</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3722387</ID>
              </Citation>
              <XRef DB="OMIM" ID="611804" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an Algerian family with hereditary elliptocytosis caused by deficiency of erythroid protein 4.1 (described by Tchernia et al., 1981; defect partially characterized by Conboy et al., 1986), Conboy et al. (1993) delineated the defect by study of erythroid and nonerythroid cells in 1 of the homozygously affected sibs. The molecular lesion was shown to involve deletion of the downstream AUG initiation codon in 4.1 mRNA, thus leading to the absence of protein 4.1 in red cells. In contrast, isoforms that use the upstream AUG were detected in nonerythroid cells, thus explaining the absence of manifestations in other organ systems. The lesion consisted of a 318-nucleotide deletion that encompassed the downstream AUG but left the upstream AUG intact. Normally, multiple protein 4.1 isoforms are expressed in a variety of tissues through complex alternative pre-mRNA splicing events, one function of which is to regulate use of 2 alternative translation initiation signals. Late erythroid cells express mainly the downstream initiation site for synthesis of prototypic 80-kD isoforms; nonerythroid cells in addition use an upstream site to encode higher molecular mass isoform(s).</Attribute>
              <Citation>
                <ID Source="PubMed">6894932</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3194408</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2384598</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPB41" />
          </GeneList>
          <Name>EPB41, 318-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">318-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="130500.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ELLIPTOCYTOSIS 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38470" TraitType="Disease" MappingType="Name" MappingValue="ELLIPTOCYTOSIS 1" MappingRef="Preferred">
        <MedGen CUI="C2678497" Name="Elliptocytosis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

